Loading...
NPI 1699946509 · Lafayette, LA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Corporation Of America is a clinical medical laboratory provider located in Lafayette, Louisiana. This profile covers 219 Medicare and 209 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Corporation Of America |
| Address | 217 La Rue France |
| City | Lafayette |
| State | LA |
| ZIP | 70508 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 19, 2008 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $12.4M |
| Medicare | $1.9M |
This provider is heavily Medicaid‑focused: reported Medicaid revenue is $12.4M versus Medicare revenue of $1.9M, indicating the provider’s billing footprint in this market is dominated by state payer volume rather than Medicare. The disparity in scale suggests operations and commercial strategy are likely oriented toward high-volume Medicaid contracts and specimen throughput.
Revenue concentration is meaningful on both payers: the top three Medicare codes account for 36.2% of Medicare revenue, and the top three Medicaid codes account for 37.6% of Medicaid revenue. On Medicare the largest individual drivers are 80053 ($178.3K), 80061 ($172.7K), and 84443 ($172.5K), while on Medicaid the top drivers are 80050 ($1.4M), 82306 ($1.2M), and 80061 ($980.5K), showing a mix of routine chemistry panels and high-volume analytes underpinning most revenue.
The code mix indicates a high‑throughput clinical laboratory operation focused on routine chemistry and endocrine testing plus population screening: frequent use of panel codes (80050, 80053, 80061) and analytes like 82306 (vitamin D), 84443 (TSH) and 83036 (A1C) point to centralized processing of ambulatory/outpatient specimens. Medicaid activity additionally shows very large volumes of NAAT STI testing (87591, 87491) and HIV-related assays (87389, 86360), implying the lab serves public‑health screening and sexually transmitted infection workflows in the state.
The provider is a dominant in‑state Medicaid submitter for many common tests: multiple Medicaid codes rank at #1 in Louisiana and are labeled “extreme outlier, far above typical state volume,” including 80050 ($1.4M), 82306 ($1.2M), 80061 ($980.5K), 83036 ($465.2K) and 87086 ($347.9K). Those state top ranks and extreme‑outlier labels indicate the provider captures a leading share of Medicaid testing for routine panels and selected microbiology in Louisiana.
Nationally on Medicare the provider reports very high absolute volumes for routine laboratory codes but these are characterized as “typical, unremarkable volume” relative to national peers: 80053 ranks #139 of 26416 (99th percentile), 80061 ranks #120 of 21671 (99th percentile), and 84443 ranks #130 of 19722 (99th percentile). In plain terms, the provider is among the large national submitters for common lab assays but its Medicare pattern aligns with other major clinical laboratories rather than being unusually concentrated or atypical.
Microbiology and infectious‑disease testing are material across both payers: culture and susceptibility codes such as 87086 (Medicare revenue $51.5K, Medicaid $347.9K) and 87186 (Medicare $30.5K, Medicaid $138.7K) appear in the top lists, and Medicaid ranks for many of these are extreme outliers in‑state. This mix signals the lab performs both quantitative urine cultures and downstream susceptibility testing at scale for the Medicaid population while maintaining meaningful, if smaller, Medicare microbiology volume.
Specialized and definitive testing contributes a smaller but visible share of revenue: definitive drug testing G0481 appears on both lists (Medicare $15.6K, Medicaid $101.3K) and higher‑unit assays such as G0103 (PSA, Medicare $35.6K) and portions of HIV viral load testing (87536, Medicaid $312.9K) are present. These entries suggest the lab combines high-volume screening/panel work with a nontrivial portfolio of higher‑complexity diagnostic assays.
The provider’s NPI has been enumerated since 2008-03-19 (≈18 years ago), which, together with the large Medicaid volumes and numerous top‑ranked in‑state codes, supports the view that this is an established laboratory operation with sustained specimen processing capacity and longstanding participation in state Medicaid networks.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
219 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 17,830 | $10 | $178.3K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 13,290 | $10 | $172.7K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 10,780 | $20 | $172.5K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 5,760 | $30 | $167.1K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 16,760 | $10 | $134.1K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 14,460 | $10 | $115.7K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 8,030 | $10 | $80.3K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 6,440 | $10 | $51.5K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 1,870 | $20 | $35.6K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 850 | $40 | $34.1K |
Showing 1–10 of 219
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 219 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
209 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 75,930 | $20 | $1.4M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 83,140 | $10 | $1.2M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 163,420 | $10 | $980.5K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 23,620 | $30 | $684.9K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 23,600 | $30 | $684.4K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 118,130 | $1 | $472.5K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 116,310 | $1 | $465.2K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 65,240 | $10 | $391.4K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 86,960 | $1 | $347.9K |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 6,800 | $50 | $312.9K |
Showing 1–10 of 209
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
209 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 71 | 100 | 620 | $40 | $560K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 16 | 30 | 1,340 | $60 | $499.3K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 83 | 90 | 650 | $40 | $404.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 61 | 170 | 1,360 | $30 | $190K |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 4 | 20 | 1,960 | $50 | $162.8K |
| 83021 | The lab analyst measures and calculates the hemoglobin fractions in a whole blood sample demonstrated by this hemoglobin fractionation test by chromatography. | 23 | 20 | 160 | $10 | $140.7K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 12 | 190 | 1,000 | $30 | $139.9K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 12 | 190 | 900 | $30 | $137.2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 53 | 50 | 1,310 | $10 | $136K |
| 83498 | The lab analyst measures the 17 hydroxyprogesterone in a sample such as blood, serum, urine, or even amniotic fluid. This hormone is a building block for the adrenal cortex hormone cortisol. | 3 | 10 | 540 | $20 | $127K |
Showing 1–10 of 209
Other providers in the same ZIP code as Laboratory Corporation Of America, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Acadian Ambulance Service, Inc. | LA | Air Ambulance | $38.7M | $422.7M |
| Pediatric Group Of Acadiana, LLC | LA | Specialist | $0 | $57.5M |
| Leading Health Care Of La | LA | In Home Supportive Care Agency | $0 | $57.4M |
| Our Lady Of Lourdes Regional Medical Center, Inc | LA | General Acute Care Hospital | $0 | $54.3M |
| Sleep Management, L.L.C. | LA | Oxygen Equipment & Supplies (DME) | $0 | $41.8M |
| Medi Trans, LLC | LA | Transportation Broker | $0 | $29.8M |
| L & D Community Care, Inc | LA | In Home Supportive Care Agency | $0 | $24.4M |
| Acadiana Acute Care Associates, LLC | LA | Emergency Medicine Physician | $0 | $20.4M |
| Lourdes After Hours LLC | LA | Urgent Care Clinic/Center | $0 | $20.2M |
| Leading Health Care Of La | LA | In Home Supportive Care Agency | $0 | $12.8M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.